Deprecated: Function get_magic_quotes_gpc() is deprecated in /home/uchis2/domains/uchisearch.com/public_html/category.php on line 152

Notice: Undefined property: stdClass::$live in /home/uchis2/domains/uchisearch.com/public_html/category.php on line 469

Notice: Undefined property: stdClass::$live in /home/uchis2/domains/uchisearch.com/public_html/category.php on line 474

Notice: Undefined variable: type in /home/uchis2/domains/uchisearch.com/public_html/category.php on line 560

Notice: Undefined variable: sortString in /home/uchis2/domains/uchisearch.com/public_html/category.php on line 563
BIOAVAILABILITY

BIOAVAILABILITY

Brand Owner Address Description
BIOAVAILABILITY OPTIMIZATION TECHNOLOGY CritiTech Drug Development Services 1849 E 1450 Road Lawrence KS 66044 BIOAVAILABILITY;Scientific research services; Pharmaceutical research and development, namely, screening drug targets; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of drug development; Conducting scientific feasibility studies; Pharmaceutical research services, namely, screening and identifying optimal active pharmaceutical ingredient (API) forms, optimized final dosing forms, dosing profiles, optimal formulation of pharmaceutical products, determination of drug substance state for enhanced bioavailability, ingredient compatibility screening, solid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product development, optimization of optimal active pharmaceutical ingredient (API) design, formulation of pharmaceutical products and drug product design;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention describes compounds, compositions and methods of using the same comprising lysine covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.